High relationship between ciprofloxacin use and prevalence of ESBL Klebsiella pneumoniae;Alta correlación entre el consumo de ciprofloxacina y la prevalencia de Klebsiella pneumonias productora de β-lactamasas de espectro extendido

Revista Chilena de Infectologia

Volumn 23, Issue 4, 2006, Pages

  Bermejo, Joaquín ^a   Bencomo, Blanca ^b   Arnesi, Nora ^c   Lesnaberes, Patricia ^a   Borda, Noemí ^d   Notario, Rodolfo ^d  

^a Unidad de Enfermedades Infecciosas   (Spain)

^b Farmacia ^*

^c Departamento de Estadística

^d Servicio de Microbiología   (Spain)

Author keywords

Ciprofloxacin; Extended spectrum betalactamases; Klebsiella pneumoniae

Indexed keywords

EID: 33845477252     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sirot D, Sirot J, Labia R, Moraud A, Courvalin P, Darfeuille-Michaud A, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987; 20: 323-34.
2. Brun-Buisson C, Legrand P, Philippen A, Montravers F, Ansquer M, Dural J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 2: 302-6.
3. Harris AD, Karchmer T B, Carmeli Y, Samore M. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review. Clin Infect Dis 2001; 32: 1055-61.
4. Schiappa D A, Hayden M K, Matushek M G, Hashemi F N, Sullivan J, Smith K Y, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation. J Infect Dis 1996; 17: 529-36.
5. Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-Kp) in the intensive care unit. J Hosp Infect 1997; 35: 9-16.
6. Asensio A, Oliver A, González-Diego P, Baquero F, Pérez-Díaz JC, Ros P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30: 55-60.
7. Arpin C, Rogues A M, Kabouche S, Boulard G, Quesnel C, Gachie JP, et al. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit. Epidemiol Infect 2000; 124: 401-8.
8. Wiener J, Quinn J P, Bradford P A, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
9. Lautenbach E, Patel J B, Bilker W B, Edelstein P H, Fishman NO. Extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32: 1162-71.
10. Bermejo J, Lesnaberes P, Arnesi N, Gianello M, Notario R, Borda N, et al. Factores asociados a infecciones por Klebsiella pneumoniae resistentes a ceftacidima. Enferm Infecc Microbiol Clin 2003; 21: 72-6.
11. McGowan J E. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033-48.
12. Oewns R C, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis 2006; 42: S173-81.
13. Sanyal S C, Mokaddas E M. The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. J Chemother 1999; 11: 28-33.
14. Landman D, Chockalingam M, Quäle J M. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28: 1062-6.
15. Paterson D, Mulazimoglu L, Casellas J M, Ko W, Goossenns H, Gottberg A V, et al. Epidemiology of ciprofloxacin resístance and its relationship to extended spectrum beta lactamase production in K pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473-8.
16. Farmer III J J. Chapter 41: Enterobacteriaceae: Introduction and identification. In Murray, P.R. (Editor in chief), Baron EJ, Jorgensen JH, Pfaller M A, Yolken RH. (ed). Manual of Clinical Microbiology 8th ed. ASM Press, Washington 2003; 636-53.
17. CLSI Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. M100-S15. Vol 25 No1. Wayne. 2005.
18. Legrand P, Fournier G, Bure A, Jarlier V, Nicolás M H, Deere D, et al. Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four french hospitals. Eur J Clin Microbiol Infect Dis 1989; 8: 527-9.
19. Peña C, Pujol M, Ardanuy C, Ricart A, Pallares R, Liñares J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum beta-lactamases. Antimicrob Agents Chemother 1998; 42: 53-8.
20. Lautenbach E, LaRosa LA, Marr A M, Nachamkin I, Bilker W B, Fishman N O. Changes in the prevalence of vancomycin-resistant Enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003; 36: 440-6.
21. Ochs M M, Me Cusker M P, Bains M, Hancock R E. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob Agents Chemother 1999; 43: 1085-90.
22. Martínez-Martínez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797-9.
23. Corkill J E, Anson J J, Hart C A. High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother 2005; 56: 1115-7.
24. Harbarth S, Harris A D, Carmeli Y, Samore M. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram-negative bacilli. Clin Infect Dis 2001; 33: 1462-8.
25. Friedrich L V, White R L, Bosso J A. Impact of use of multiple antimicrobial on changes in susceptibility of Gram-negative aerobes. Clin Infect Dis 1999; 28: 1017-24.